Upper airway disorders are traditionally approached as localized conditions affecting the nasal cavity, paranasal sinuses, pharynx, and related structures. However, accumulating evidence indicates that these disorders exert clinically meaningful systemic effects through interconnected physiological, inflammatory, and neurohumoral mechanisms. This narrative integrative review examines the systemic clinical implications of major upper airway disorders, including obstructive sleep apnea, allergic rhinitis, chronic rhinosinusitis, and tonsillopharyngitis. The analysis integrates epidemiological data, mechanistic insights, and clinical outcome evidence to characterize how upper airway dysfunction contributes to cardiovascular disease, metabolic dysregulation, neurocognitive impairment, immune and inflammatory alterations, and lower-airway comorbidity. The findings highlight distinct systemic association profiles across conditions: obstructive sleep apnea demonstrates strong links with cardiovascular, metabolic, and neurocognitive domains, whereas allergic rhinitis and chronic rhinosinusitis are more closely associated with immune-mediated pathways and lower-airway disease within the unified airway framework. Tonsillopharyngitis shows a more focused inflammatory profile with limited multisystem extension. Collectively, the evidence supports a systems-based perspective in which upper airway disorders are understood as modifiers of systemic health rather than isolated local diseases. This integrative approach has important implications for medical education, interdisciplinary clinical practice, and early identification of systemic risk, particularly in healthcare contexts with high burdens of chronic disease.